COPD and Osteoporosis: Associated Factors in Patients Treated with Inhaled Corticosteroids

References

• ConsensusA. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646–650. doi:10.1016/0002-9343(93)90218-E8506892
   PubMed Web of Science ®Google Scholar
• ChenYW, RamsookAH, CoxsonHO, BonJ, ReidWD. Prevalence and risk factors for osteoporosis in individuals with COPD: a systematic review and meta-analysis. Chest. 2019;156(6):1092–1110. doi:10.1016/j.chest.2019.06.03631352034
   PubMed Web of Science ®Google Scholar
• DenizS, SengulA, AydemirY, Celdir EmreJ, OzhanMH. Clinical factors and comorbidities affecting the cost of hospital-treated COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:3023–3030. doi:10.2147/COPD.S12063727980399
   PubMed Web of Science ®Google Scholar
• LinCW, ChenYY, ChenYJ, LiangCY, LinMS, ChenW. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis. 2015;10:1493–1500.26251589
   PubMed Web of Science ®Google Scholar
• Pascual-GuardiaS, Badenes-BonetD, Martin-OntiyueloC, et al. Hospital admissions and mortality in patients with COPD exacerbations and vertebral body compression fractures. Int J Chron Obstruct Pulmon Dis. 2017;12:1837–1845. doi:10.2147/COPD.S12921328684906
   PubMed Web of Science ®Google Scholar
• Graat-VerboomL, SpruitMA, van den BorneBE, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease: an underestimated systemic component. Respir Med. 2009;103(8):1143–1151. doi:10.1016/j.rmed.2009.02.01419304474
   PubMed Web of Science ®Google Scholar
• OkazakiR, WatanabeR, InoueD. Osteoporosis Associated with chronic obstructive pulmonary disease. Chron Obstruct Pulmon Dis. 2016;23(3):111–120. doi:10.11005/jbm.2016.23.3.111
   Google Scholar
• InoueD, WatanabeR, OkazakiR. COPD and osteoporosis: links, risks, and treatment challenges. Int J Chron Obstruct Pulmon Dis. 2016;11:637–648. doi:10.2147/COPD.S7963827099481
   PubMed Web of Science ®Google Scholar
• KanisJA, KanisJA. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int. 1994;4(6):368–381. doi:10.1007/BF16222007696835
   PubMed Web of Science ®Google Scholar
• LiangB, FengY. The association of low bone mineral density with systemic inflammation in clinically stable COPD. Endocrine. 2012;42(1):190–195. doi:10.1007/s12020-011-9583-x22198912
   PubMed Web of Science ®Google Scholar
• WatanabeR, TanakaT, AitaK, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab. 2015;33(4):392–400. doi:10.1007/s00774-014-0605-724996527
   PubMed Web of Science ®Google Scholar
• Ogura-TomomatsuH, AsanoK, TomomatsuK, et al. Predictors of osteoporosis and vertebral fractures in patients presenting with moderate-to-severe chronic obstructive lung disease. COPD. 2012;9(4):332–337. doi:10.3109/15412555.2012.66785022489911
   PubMedGoogle Scholar
• CompstonJ. Glucocorticoid-induced osteoporosis: an update. Endocrine. 2018;61(1):7–16.29691807
   PubMed Web of Science ®Google Scholar
• HayatS, MagreyMN. Glucocorticoid-induced osteoporosis: insights for the clinician. Cleve Clin J Med. 2020;87(7):417–426. doi:10.3949/ccjm.87a.1903932605977
   PubMed Web of Science ®Google Scholar
• AdamiG, SaagKG. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos Int. 2019;30(6):1145–1156. doi:10.1007/s00198-019-04906-x30805679
   PubMed Web of Science ®Google Scholar
• JonesA, FayJK, BurrM, StoneM, HoodK, RobertsG. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002;1:CD003537.
   Google Scholar
• SuissaS, BaltzanM, KremerR, ErnstP. Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med. 2004;169(1):83–88. doi:10.1164/rccm.200305-640OC14551165
   PubMed Web of Science ®Google Scholar
• HubbardR, TattersfieldA, SmithC, WestJ, SmeethL, FletcherA. Use of inhaled corticosteroids and the risk of fracture. Chest. 2006;130(4):1082–1088. doi:10.1378/chest.130.4.108217035441
   PubMed Web of Science ®Google Scholar
• MathioudakisAG, AmanetopoulouSG, GialmanidisIP, et al. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? Respirology. 2013;18(1):147–153. doi:10.1111/j.1440-1843.2012.02265.x22985270
   PubMed Web of Science ®Google Scholar
• VestboJ, HurdSS, AgustiAG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP22878278
   PubMed Web of Science ®Google Scholar
• BurgeS, WedzichaJA. COPD exacerbations: definitions and classifications. Eur Respir J Suppl. 2003;41:46s–53s. doi:10.1183/09031936.03.0007800212795331
   PubMedGoogle Scholar
• FergusonGT, CalverleyPMA, AndersonJA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a revolution in COPD Health study. Chest. 2009;136(6):1456–1465. doi:10.1378/chest.08-301619581353
   PubMed Web of Science ®Google Scholar
• JohnellO, PauwelsR, LofdahlCG, et al. Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler. Eur Respir J. 2002;19(6):1058–1063. doi:10.1183/09031936.02.0027660212108857
   PubMed Web of Science ®Google Scholar
• ScanlonPD, ConnettJE, WiseRA, et al. Loss of bone density with inhaled triamcinolone in Lung Health Study II. Am J Respir Crit Care Med. 2004;170(12):1302–1309. doi:10.1164/rccm.200310-1349OC15374846
   PubMed Web of Science ®Google Scholar
• CaramoriG, RuggeriP, ArpinelliF, SalviL, GirbinoG. Long-term use of inhaled glucocorticoids in patients with stable chronic obstructive pulmonary disease and risk of bone fractures: a narrative review of the literature. Int J Chron Obstruct Pulmon Dis. 2019;14:1085–1097. doi:10.2147/COPD.S19021531190791
   PubMed Web of Science ®Google Scholar
• GanWQ, ManSF, SenthilselvanA, SinDD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580. doi:10.1136/thx.2003.01958815223864
   PubMed Web of Science ®Google Scholar
• WatanabeK, OnoueA, KubotaK, et al. Association between airflow limitation severity and reduced bone mineral density in Japanese men. Int J Chron Obstruct Pulmon Dis. 2019;14:2355–2363. doi:10.2147/COPD.S21374631695355
   PubMed Web of Science ®Google Scholar
• MasalaS, MagriniA, TaglieriA, et al. Chronic obstructive pulmonary disease (COPD) patients with osteoporotic vertebral compression fractures (OVCFs): improvement of pulmonary function after percutaneous vertebroplasty (VTP). Eur Radiol. 2014;24(7):1577–1585. doi:10.1007/s00330-014-3165-224744201
   PubMed Web of Science ®Google Scholar
• WuSS, LachmannE, NaglerW. Current medical, rehabilitation, and surgical management of vertebral compression fractures. J Womens Health. 2003;12(1):17–26. doi:10.1089/154099903321154103
   Web of Science ®Google Scholar
• KanisJA, JohnellO, OdenA, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int. 2005;16(2):155–162. doi:10.1007/s00198-004-1640-315175845
   PubMed Web of Science ®Google Scholar
• WardKD, KlesgesRC. A meta-analysis of the effects of cigarette smoking on bone mineral density. Calcif Tissue Int. 2001;68(5):259–270. doi:10.1007/BF239083211683532
   PubMed Web of Science ®Google Scholar
• JiangX, GoodLE, SpinkaR, SchnatzPF. Osteoporosis screening in postmenopausal women aged 50–64 years: BMI alone compared with current screening tools. Maturitas. 2016;83:59–64. doi:10.1016/j.maturitas.2015.09.00926471931
   PubMed Web of Science ®Google Scholar
• ZewariS, HadiL, van den ElshoutF, DekhuijzenR, HeijdraY, VosP. Obesity in COPD: comorbidities with practical consequences? COPD. 2018;15(5):464–471. doi:10.1080/15412555.2018.150995130512982
   PubMedGoogle Scholar
• SpeltaF, Fratta PasiniAM, CazzolettiL, FerrariM. Body weight and mortality in COPD: focus on the obesity paradox. Eat Weight Disord. 2018;23(1):15–22. doi:10.1007/s40519-017-0456-z29110280
   PubMed Web of Science ®Google Scholar
• CostaTM, CostaFM, MoreiraCA, RabeloLM, BoguszewskiCL, BorbaVZ. Sarcopenia in COPD: relationship with COPD severity and prognosis. J Bras Pneumol. 2015;41(5):415–421. doi:10.1590/S1806-3713201500000004026578132
   PubMed Web of Science ®Google Scholar